The Food and Drug Administration has green-lighted a pilot program using blockchain and internet of things to track to track and verify specialty prescription drugs.
The pilot will focus on intra- and interhealth system medication transport and use in North Carolina, Indiana and Tennessee, and looks at how blockchain and IoT technology could be used to monitor specialty medication distribution across supply chains, according to an April 25 release.
Rymedi, Temptime/Zebra, Indiana University Health, WakeMed Health & Hospitals, Good Shepherd Pharmacy and the Center for Supply Chain Studies and the Global Health Policy Institute make up the pilot consortium.
"Applying emerging technologies alongside regulatory standards development will not only ensure safe, quality products in healthcare, but will also display how our industry is evolving and working towards connected care innovation,” Rymedi CEO David Stefanich said in a statement.
The group plans to also explore new best practices for health care system data sharing and coordination.